




Iodinated X-ray contrast media (ICM), used 
medically to highlight soft tissues, are con-
sidered generally safe, and patients excrete 
95% of the dose within 24 hours, making 
them  a  valuable  tool  in  medical  imaging. 
But a new study shows that excreted ICM 
react with chloramine and chlorine at water 
treatment  plants  to  form  toxic  iodinated 
disinfection  by-products  (iodo-DBPs).
1 
“ICM are definitely a source of iodo-DBPs 
in  drinking  water,”  says  study  coauthor 
Susan  Richardson,  a  research  chemist  at 
the U.S. Environmental Protection Agency 
(EPA) in Athens, Georgia, although she says 
natural  iodide  salts  from  saltwater  intru-
sion are probably the major source of these 
contaminants.
In  an  earlier  study  of  drinking  water 
collected  from  23  cities,  Richardson  and 
toxicologist Michael Plewa of the University 
of Illinois at Urbana–Champaign detected 
iodo-acids and iodo-trihalomethanes, both 
highly  toxic  iodo-DBPs.
2  They  assumed 
that  the  source  of  iodine  was  natural 
iodide salts from intrusion of ocean water 
or  natural  minerals  in  the  source  water. 
Yet  surprisingly,  some  samples  had  high 
concentrations  of  iodo-DBPs  despite  little 
or no detectable natural iodide in the water. 
Their new study, done in collaboration with 
Stephen Duirk at the University of Akron 
and Thomas Ternes at the German Federal 
Institute of Hydrology, suggests that ICM, 
which contain three iodines per molecule, 
were an unexpected source of iodine in 10 
of the original 23 cities. Further laboratory 
tests confirmed that ICM form iodo-DBPs 
in the presence of chlorine and chloramine, 
which are commonly used to treat drinking 
water.
1
ICM  are  nearly  impossible  to  remove 
from water by conventional treatment meth-
ods,  says  environmental  engineer  David 
Sedlak,  codirector  of  the  Berkeley  Water 
Center  at  the  University  of  California, 
Berkeley, and the compounds end up in riv-
ers used for drinking water.
3 Richardson’s 
team screened drinking water for five com-
mon ICM (io  pamidol, iopromide, diatrizo-
ate, iomeprol, and iohexol). Iopamidol was 
detected in the highest concentrations—up 
to  2,700  ng/L,  compared  with  less  than 
100  ng/L  for  the  majority  of  the  other 
ICM—and was chosen as the test ICM for 
controlled  experiments. 
When  iopamidol  was 
dissolved in river water 
spiked with chlorine or 
chloramine,  high  levels 
of  iodoacetic  acid  and 
iodo-trihalomethanes 
were produced in a dose-
dependent  manner.  In 
comparison, no iodo-DBPs 
formed in the absence of 
iopamidol  in  river  water 
containing the two disin-
fectants. Iodo-DBPs form 
best at pH 6.5–8.5, con-
ditions common at water 
treatment plants.
1 
ICM are a major medi-
cal  breakthrough—“We 
don’t  want  to  stop  using 
them,”  Richardson  says. 
Other types of ICM may 
form lower concentra-
tions  of  iodo-DBPs  than 
io  pamidol, and Richardson 
will test this hypothesis and 
seek insight into how ICM 
interact with chlorinated disinfectants. Better 
understanding  of  the  reactions involved 
could ultimately prevent toxic by-products. 
More than 600 DBPs are known, and 
Plewa’s laboratory has systematically analyzed 
about 80 for genotoxicity and cytotoxicity in 
mammalian cells. Iodo-DBPs are more toxic 
than  brominated  and  chlorinated  analogs, 
and iodoacetic acid is the most genotoxic of 
all DBPs tested so far.
4 Iodo-DBPs are being 
investigated for links to bladder cancer and 
birth  defects.
5,6  The  EPA  regulates  some 
chlorinated and brominated DBPs in drink-
ing water but not iodo-DBPs, whose toxicity 
is only just being recognized.
7
“We  don’t  think  about  disinfection  of 
drinking  water  modifying  water  contami-
nants  and  generating  enhanced  toxicity,” 
Plewa says. In this case, he says, “A pharma-
ceutical with absolutely no genotoxicity [i.e., 
ICM]  forms  highly  genotoxic  iodo-DBPs. 
How many other reactions with exogenous 
agents occur when water is disinfected for 
drinking?” Plewa points out that this toxic 
transformation  of  ICM  differs  from  the 
impact  of  other  pharmaceutical  contami-
nants in water, such as estrogenic hormones, 
which directly cause adverse responses.
It’s been assumed that the presence of 
ICM  in  drinking  water  poses  no  human 
health concerns. “But when ICM are trans-
formed  into  compounds  that  are  more 
toxic than the parent compound, it raises 
questions about assessing the potential risks 
associated  with  discharging  these  com-
pounds into the environment,” Sedlak says. 
His research shows that ICM in wastewater 
are largely found near hospitals and imaging 
laboratories.
8 “It would be straight  forward 
to collect and treat these compounds at the 
source,” Sedlak says. Plewa offers a practical 
solution: “Patients given ICM could urinate 
before leaving hospitals, and the collected 
urine  could  be  safely  disposed  of  at  the 
hospital.”
Carol  Potera,  based  in  Montana, has  written  for  EHP  since 
1996. She also writes for Microbe, Genetic Engineering News, 
and the American Journal of Nursing.
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